Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507176 | SCV000604074 | likely pathogenic | not specified | 2017-01-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001062527 | SCV001227334 | pathogenic | Spastic paraplegia | 2023-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg772*) in the KIF5A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KIF5A are known to be pathogenic (PMID: 26374131). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KIF5A-related conditions. ClinVar contains an entry for this variant (Variation ID: 439849). For these reasons, this variant has been classified as Pathogenic. |